Andreas Scorilas

Andreas Scorilas's AcademicInfluence.com Rankings

Andreas Scorilas

Philosophy

#8304

World Rank

#11657

Historical Rank

Logic

#5340

World Rank

#6731

Historical Rank

philosophy Degrees

Download Badge

Philosophy

Why Is Andreas Scorilas Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Andreas Scorilas's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Overexpression of matrix-metalloproteinase-9 in human breast cancer: a potential favourable indicator in node-negativeatients (2001) (261)
BCL2 Family of Apoptosis-Related Genes: Functions and Clinical Implications in Cancer (2006) (243)
Human kallikrein 6 (hK6): a new potential serum biomarker for diagnosis and prognosis of ovarian carcinoma. (2003) (210)
The Role of BCL2 Family of Apoptosis Regulator Proteins in Acute and Chronic Leukemias (2011) (207)
Genomic organization of the human kallikrein gene family on chromosome 19q13.3-q13.4. (2000) (201)
The serum concentration of human kallikrein 10 represents a novel biomarker for ovarian cancer diagnosis and prognosis. (2003) (167)
Evaluation of PD-L1 Expression and Associated Tumor-Infiltrating Lymphocytes in Laryngeal Squamous Cell Carcinoma (2015) (161)
The miR-17-92 cluster is over expressed in and has an oncogenic effect on renal cell carcinoma. (2010) (160)
Parallel overexpression of seven kallikrein genes in ovarian cancer. (2003) (157)
A new tumor suppressor role for the Notch pathway in bladder cancer (2014) (156)
Human kallikrein gene 5 (KLK5) expression is an indicator of poor prognosis in ovarian cancer (2001) (156)
The human KLK8 (neuropsin/ovasin) gene: identification of two novel splice variants and its prognostic value in ovarian cancer. (2001) (147)
Human kallikrein 5: a potential novel serum biomarker for breast and ovarian cancer. (2003) (143)
A comprehensive nomenclature for serine proteases with homology to tissue kallikreins (2006) (141)
Higher human kallikrein gene 4 (KLK4) expression indicates poor prognosis of ovarian cancer patients. (2001) (140)
Lactate Dehydrogenase A is a potential prognostic marker in clear cell renal cell carcinoma (2014) (139)
Hepsin is highly over expressed in and a new candidate for a prognostic indicator in prostate cancer. (2004) (133)
The combination of human glandular kallikrein and free prostate-specific antigen (PSA) enhances discrimination between prostate cancer and benign prostatic hyperplasia in patients with moderately increased total PSA. (1999) (131)
The PRMT1 gene expression pattern in colon cancer (2008) (129)
Structure and biological properties of the copper(II) complex with the quinolone antibacterial drug N-propyl-norfloxacin and 2,2'-bipyridine. (2007) (128)
Prognostic value of human kallikrein 10 expression in epithelial ovarian carcinoma. (2001) (123)
Molecular Cloning of the Human Kallikrein 15 Gene (KLK15) (2001) (122)
Decreased concentrations of prostate-specific antigen and human glandular kallikrein 2 in malignant versus nonmalignant prostatic tissue. (2000) (116)
The clinical utility of miR-21 as a diagnostic and prognostic marker for renal cell carcinoma. (2012) (115)
Quantitative expression of the human kallikrein gene 9 (KLK9) in ovarian cancer: a new independent and favorable prognostic marker. (2001) (115)
Human kallikrein 10: a novel tumor marker for ovarian carcinoma? (2001) (114)
Serum human glandular kallikrein-2 protease levels predict the presence of prostate cancer among men with elevated prostate-specific antigen. (2000) (110)
Human kallikrein gene 5 (KLK5) expression by quantitative PCR: an independent indicator of poor prognosis in breast cancer. (2002) (105)
Quantitative analysis of macrophage inhibitory cytokine-1 (MIC-1) gene expression in human prostatic tissues (2003) (100)
The KLK7 (PRSS6) gene, encoding for the stratum corneum chymotryptic enzyme is a new member of the human kallikrein gene family - genomic characterization, mapping, tissue expression and hormonal regulation. (2000) (97)
Human kallikrein 8, a novel biomarker for ovarian carcinoma. (2003) (94)
Molecular cloning, physical mapping, and expression analysis of a novel gene, BCL2L12, encoding a proline-rich protein with a highly conserved BH2 domain of the Bcl-2 family. (2001) (93)
The loss of the tumour-suppressor miR-145 results in the shorter disease-free survival of prostate cancer patients (2013) (90)
Phosphatidylinositol 3′-Kinase Catalytic Subunit α Gene Amplification Contributes to the Pathogenesis of Mantle Cell Lymphoma (2009) (90)
Immunofluorometric quantitation and histochemical localisation of kallikrein 6 protein in ovarian cancer tissue: a new independent unfavourable prognostic biomarker (2002) (87)
Kallikrein-related peptidases in prostate, breast, and ovarian cancers: from pathobiology to clinical relevance (2012) (84)
Kallikrein-related peptidases (KLKs): a gene family of novel cancer biomarkers (2012) (83)
Human kallikrein 13 protein in ovarian cancer cytosols: a new favorable prognostic marker. (2004) (83)
Non-coding RNAs: the riddle of the transcriptome and their perspectives in cancer. (2018) (79)
Detection of human kallikrein 4 in healthy and cancerous prostatic tissues by immunofluorometry and immunohistochemistry. (2002) (78)
Apoptosis-related BCL2-family members: Key players in chemotherapy. (2014) (78)
The lysine‐specific methyltransferase KMT2C/MLL3 regulates DNA repair components in cancer (2019) (78)
Prognostic value of quantitatively assessed KLK7 expression in ovarian cancer. (2003) (77)
Genomic organization, physical mapping, and expression analysis of the human protein arginine methyltransferase 1 gene. (2000) (76)
Clinical evaluation of PRMT1 gene expression in breast cancer (2011) (76)
TNF-alpha expression and apoptosis-regulating proteins in oral lichen planus: a comparative immunohistochemical evaluation. (2000) (74)
Differential protein expressions in renal cell carcinoma: new biomarker discovery by mass spectrometry. (2009) (74)
Expression analysis of the human kallikrein 7 (KLK7) in breast tumors: a new potential biomarker for prognosis of breast carcinoma (2003) (73)
The chromatin remodeling gene ARID1A is a new prognostic marker in clear cell renal cell carcinoma. (2013) (73)
Genomic organization, mapping, tissue expression, and hormonal regulation of trypsin-like serine protease (TLSP PRSS20), a new member of the human kallikrein gene family. (2000) (73)
Kallikrein-related peptidase genes as promising biomarkers for prognosis and monitoring of human malignancies (2010) (72)
RAS/PI3K Crosstalk and Cetuximab Resistance in Head and Neck Squamous Cell Carcinoma (2014) (72)
Prognostic value of the apoptosis related genes BCL2 and BCL2L12 in breast cancer. (2007) (72)
Steroid hormone regulation and prognostic value of the human kallikrein gene 14 in ovarian cancer. (2003) (72)
Down‐regulation of the human kallikrein gene 5 (KLK5) in prostate cancer tissues (2002) (71)
Cathepsin B and cathepsin D expression in the progression of colorectal adenoma to carcinoma. (2004) (70)
A Multiparametric Panel for Ovarian Cancer Diagnosis, Prognosis, and Response to Chemotherapy (2007) (70)
Prognostic value of the human kallikrein gene 15 expression in ovarian cancer. (2003) (69)
Differential expression of the human kallikrein gene 14 (KLK14) in normal and cancerous prostatic tissues (2003) (69)
Colon cancer and protein arginine methyltransferase 1 gene expression. (2009) (68)
Favorable prognostic value of tissue human kallikrein 11 (hK11) in patients with ovarian carcinoma (2003) (68)
Uncovering the clinical utility of miR-143, miR-145 and miR-224 for predicting the survival of bladder cancer patients following treatment. (2015) (67)
Human kallikrein gene 13 (KLK13) expression by quantitative RT–PCR: an independent indicator of favourable prognosis in breast cancer (2002) (67)
Insulin-like growth factor I (IGF-I) and IGF-binding protein-3 in benign prostatic hyperplasia and prostate cancer. (2001) (67)
B7-H4 is over-expressed in early-stage ovarian cancer and is independent of CA125 expression. (2007) (67)
The usefulness of serum human kallikrein 11 for discriminating between prostate cancer and benign prostatic hyperplasia. (2003) (66)
Analytical methodologies for the detection of SARS-CoV-2 in wastewater: Protocols and future perspectives (2020) (64)
Streptavidin-polyvinylamine conjugates labeled with a europium chelate: applications in immunoassay, immunohistochemistry, and microarrays. (2000) (63)
Differential expression of Kallikrein gene 5 in cancerous and normal testicular tissues. (2002) (62)
Downregulation and prognostic performance of microRNA 224 expression in prostate cancer. (2013) (62)
Human Kallikrein 8 Protein Is a Favorable Prognostic Marker in Ovarian Cancer (2006) (62)
Effects of Long-term Androgen Administration on Breast Tissue of Female-to-Male Transsexuals (2006) (61)
Human tissue kallikreins: from gene structure to function and clinical applications. (2005) (61)
Prognostic role and implications of mutation status of tumor suppressor gene ARID1A in cancer: a systematic review and meta-analysis (2015) (61)
Quantitative analysis of kallikrein 15 gene expression in prostate tissue. (2003) (59)
Decreased concentration of human kallikrein 6 in brain extracts of Alzheimer's disease patients. (2002) (59)
The use of kallikrein-related peptidases as adjuvant prognostic markers in colorectal cancer (2009) (59)
Microvascular density as an independent predictor of clinical outcome in renal cell carcinoma: an automated image analysis study (2012) (58)
The emergence of drug resistance to targeted cancer therapies: Clinical evidence. (2019) (58)
Low expression of miR-126 is a prognostic marker for metastatic clear cell renal cell carcinoma. (2015) (58)
Immunofluorometric Quantification of Human Kallikrein 5 Expression in Ovarian Cancer Cytosols and Its Association with Unfavorable Patient Prognosis (2003) (56)
miR-210 is a prognostic marker in clear cell renal cell carcinoma. (2015) (55)
The Prognostic Value of the Human Kallikrein Gene 9 (KLK9) in Breast Cancer (2003) (55)
Determination of c-myc amplification and overexpression in breast cancer patients: evaluation of its prognostic value against c-erbB-2, cathepsin-D and clinicopathological characteristics using univariate and multivariate analysis (1999) (54)
Prognostic value and biological role of the kallikrein-related peptidases in human malignancies. (2010) (53)
Human kallikrein 11: an indicator of favorable prognosis in ovarian cancer patients. (2004) (53)
The role of cordycepin in cancer treatment via induction or inhibition of apoptosis: implication of polyadenylation in a cell type specific manner (2007) (53)
Quantitative expression analysis and prognostic significance of L-DOPA decarboxylase in colorectal adenocarcinoma (2010) (52)
The expression of the CEACAM19 gene, a novel member of the CEA family, is associated with breast cancer progression. (2013) (52)
Expression of Gelatinase-A (MMP-2) in Human Colon Cancer and Normal Colon Mucosa (2001) (52)
SARS-CoV-2 wastewater surveillance data can predict hospitalizations and ICU admissions (2021) (51)
The androgen-regulated gene human kallikrein 15 (KLK15) is an independent and favourable prognostic marker for breast cancer (2002) (50)
Polyadenylate polymerase modulations in human epithelioid cervix and breast cancer cell lines, treated with etoposide or cordycepin, follow cell cycle rather than apoptosis induction (2005) (50)
Quantitative analysis of hippostasin/KLK11 gene expression in cancerous and noncancerous prostatic tissues. (2003) (48)
Cisplatin‐Induced Apoptosis in HL‐60 Human Promyelocytic Leukemia Cells (2003) (48)
Unfavorable prognostic value of human kallikrein 7 quantified by ELISA in ovarian cancer cytosols. (2006) (48)
Human glandular kallikrein in breast milk, amniotic fluid, and breast cyst fluid. (1999) (48)
Quantitative analysis of human kallikrein gene 14 expression in breast tumours indicates association with poor prognosis (2002) (47)
Transcriptional upregulation of human tissue kallikrein 6 in ovarian cancer: clinical and mechanistic aspects (2007) (47)
Serum human glandular kallikrein (hK2) and insulin‐like growth factor 1 (IGF‐1) improve the discrimination between prostate cancer and benign prostatic hyperplasia in combination with total and %free PSA (2003) (47)
High miR-96 levels in colorectal adenocarcinoma predict poor prognosis, particularly in patients without distant metastasis at the time of initial diagnosis (2016) (46)
Quantitative analysis of the mRNA expression levels of BCL2 and BAX genes in human osteoarthritis and normal articular cartilage: An investigation into their differential expression. (2015) (45)
p27(kip1) and Ki-67 (MIB1) immunohistochemical expression in radical prostatectomy specimens of patients with clinically localized prostate cancer. (2005) (45)
Alterations in mRNA Expression of Apoptosis‐Related Genes BCL2, BAX, FAS, Caspase‐3, and the Novel Member BCL2L12 after Treatment of Human Leukemic Cell Line HL60 with the Antineoplastic Agent Etoposide (2006) (45)
The oncomiR miR-197 is a novel prognostic indicator for non-small cell lung cancer patients (2015) (44)
Determination of Cathepsin B Expression May Offer Additional Prognostic Information for Ovarian Cancer Patients (2002) (44)
Emerging clinical importance of the cancer biomarkers kallikrein-related peptidases (KLK) in female and male reproductive organ malignancies (2013) (44)
Clinical significance of kallikrein-related peptidase (KLK10) mRNA expression in colorectal cancer. (2013) (44)
Revisiting Histone Deacetylases in Human Tumorigenesis: The Paradigm of Urothelial Bladder Cancer (2019) (43)
BCL2L12 is a Novel Biomarker for the Prediction of Short-Term Relapse in Nasopharyngeal Carcinoma (2011) (43)
Breast Cancer Cells Response to the Antineoplastic Agents Cisplatin, Carboplatin, and Doxorubicin at the mRNA Expression Levels of Distinct Apoptosis‐Related Genes, Including the New Member, BCL2L12 (2007) (43)
Quantitative expression analysis and prognostic significance of the novel apoptosis-related gene BCL2L12 in colon cancer (2008) (43)
Altered kallikrein 7 and 10 concentrations in cerebrospinal fluid of patients with Alzheimer's disease and frontotemporal dementia. (2004) (43)
Immunohistochemical expression of Bcl2 is an independent predictor of time-to-biochemical failure in patients with clinically localized prostate cancer following radical prostatectomy. (2005) (42)
Correlation of androgen receptor status, neuroendocrine differentiation and angiogenesis with time-to-biochemical failure after radical prostatectomy in clinically localized prostate cancer. (2007) (42)
Expression analysis and prognostic significance of human kallikrein 11 in prostate cancer. (2005) (42)
Comparative kinetics of SARS-CoV-2 anti-spike protein RBD IgGs and neutralizing antibodies in convalescent and naïve recipients of the BNT162b2 mRNA vaccine versus COVID-19 patients (2021) (42)
mRNA expression analysis of a variety of apoptosis-related genes, including the novel gene of the BCL2-family, BCL2L12, in HL-60 leukemia cells after treatment with carboplatin and doxorubicin (2004) (42)
Expression analysis and clinical utility of L-Dopa decarboxylase (DDC) in prostate cancer. (2008) (42)
Quantitative expression analysis of the apoptosis-related genes BCL2, BAX and BCL2L12 in gastric adenocarcinoma cells following treatment with the anticancer drugs cisplatin, etoposide and taxol (2012) (42)
Clinical significance of kallikrein-related peptidase 7 (KLK7) in colorectal cancer (2009) (42)
Kallikrein-related peptidases (KLKs) in gastrointestinal cancer: Mechanistic and clinical aspects (2013) (41)
Expression of BCL2L12, a new member of apoptosis-related genes, in breast tumors (2003) (41)
MicroRNA‐194 is a Marker for Good Prognosis in Clear Cell Renal Cell Carcinoma (2016) (41)
Evolution of the Plasma and Tissue Kallikreins, and Their Alternative Splicing Isoforms (2013) (40)
Enhanced miR-182 transcription is a predictor of poor overall survival in colorectal adenocarcinoma patients (2014) (40)
Adverse effects of COVID-19 mRNA vaccines: the spike hypothesis (2022) (40)
Molecular Profile of the BCL2 Family of the Apoptosis Related Genes in Breast Cancer Cells after Treatment with Cytotoxic/Cytostatic Drugs (2008) (40)
miR-15a-5p, A Novel Prognostic Biomarker, Predicting Recurrent Colorectal Adenocarcinoma (2017) (40)
Immunoenzymatically determined pepsinogen C concentration in breast tumor cytosols: an independent favorable prognostic factor in node-positive patients. (1999) (40)
Kallikrein‐related peptidase 4 gene (KLK4) in prostate tumors: Quantitative expression analysis and evaluation of its clinical significance (2011) (39)
The novel member of the BCL2 gene family, BCL2L12, is substantially elevated in chronic lymphocytic leukemia patients, supporting its value as a significant biomarker. (2011) (39)
Impact of expression differences of kallikrein-related peptidases and of uPA and PAI-1 between primary tumor and omentum metastasis in advanced ovarian cancer. (2011) (39)
Molecular analysis and prognostic impact of the novel apoptotic gene BCL2L12 in gastric cancer. (2010) (38)
Loss of GAS5 tumour suppressor lncRNA: an independent molecular cancer biomarker for short-term relapse and progression in bladder cancer patients (2018) (38)
Polyadenylate Polymerase (PAP) and 3' End pre-mRNA Processing: Function, Assays, and Association with Disease (2002) (38)
miRNA and long non-coding RNA: molecular function and clinical value in breast and ovarian cancers (2018) (37)
Prostate-specific antigen and human glandular kallikrein 2 are markedly elevated in urine of patients with polycystic ovary syndrome. (2001) (37)
Treatment of MCF-7 cells with taxol and etoposide induces distinct alterations in the expression of apoptosis-related genes BCL2, BCL2L12, BAX, CASPASE-9 and FAS (2006) (37)
Expression analysis of BCL2L12, a new member of apoptosis-related genes, in colon cancer (2004) (37)
miR-224 overexpression is a strong and independent prognosticator of short-term relapse and poor overall survival in colorectal adenocarcinoma. (2015) (36)
Polyadenylate polymerase enzymatic activity in mammary tumor cytosols: A new independent prognostic marker in primary breast cancer. (2000) (36)
Nature promises new anticancer agents: Interplay with the apoptosis-related BCL2 gene family. (2014) (36)
Computational approaches in cancer multidrug resistance research: Identification of potential biomarkers, drug targets and drug-target interactions. (2019) (35)
A Comprehensive Phylogenetic and Structural Analysis of the Carcinoembryonic Antigen (CEA) Gene Family (2014) (35)
The role of human tissue kallikreins 7 and 8 in intracranial malignancies (2006) (35)
Kallikrein-related peptidase-6 (KLK6) mRNA expression is an independent prognostic tissue biomarker of poor disease-free and overall survival in colorectal adenocarcinoma (2014) (35)
Predictive value of c-erbB-2 and cathepsin-D for Greek breast cancer patients using univariate and multivariate analysis. (1999) (35)
Galectin-1 has potential prognostic significance and is implicated in clear cell renal cell carcinoma progression through the HIF/mTOR signaling axis (2014) (34)
Kallikrein-related peptidases (KLKs) as emerging therapeutic targets: focus on prostate cancer and skin pathologies (2016) (34)
Assessment of the prognostic significance of endoglin (CD105) in clear cell renal cell carcinoma using automated image analysis. (2012) (34)
Kallikrein-related peptidase 4 (KLK4) mRNA predicts short-term relapse in colorectal adenocarcinoma patients. (2013) (34)
Third-Generation Sequencing: The Spearhead towards the Radical Transformation of Modern Genomics (2021) (33)
Trastuzumab plus paclitaxel or docetaxel in HER-2-negative/HER-2 ECD-positive anthracycline- and taxane-refractory advanced breast cancer. (2008) (33)
The effect of the polyadenylation inhibitor cordycepin on human Molt-4 and Daudi leukaemia and lymphoma cell lines (2008) (33)
Circular RNAs: A New Piece in the Colorectal Cancer Puzzle (2020) (33)
Serum and urinary prostate-specific antigen and urinary human glandular kallikrein concentrations are significantly increased after testosterone administration in female-to-male transsexuals. (2000) (33)
Expression analysis and clinical evaluation of kallikrein-related peptidase 10 (KLK10) in colorectal cancer (2011) (33)
Molecular cloning of novel alternatively spliced variants of BCL2L12, a new member of the BCL2 gene family, and their expression analysis in cancer cells. (2012) (32)
Elevated expression of miR-24-3p is a potentially adverse prognostic factor in colorectal adenocarcinoma. (2017) (32)
MicroRNA-155-5p Overexpression in Peripheral Blood Mononuclear Cells of Chronic Lymphocytic Leukemia Patients Is a Novel, Independent Molecular Biomarker of Poor Prognosis (2017) (31)
Circular RNAs: Emerging Regulators of the Major Signaling Pathways Involved in Cancer Progression (2021) (31)
Upregulated miR-16 expression is an independent indicator of relapse and poor overall survival of colorectal adenocarcinoma patients (2017) (31)
Loss of miR-378 in prostate cancer, a common regulator of KLK2 and KLK4, correlates with aggressive disease phenotype and predicts the short-term relapse of the patients (2014) (31)
Evaluation and prognostic significance of human tissue kallikrein-related peptidase 6 (KLK6) in colorectal cancer. (2012) (31)
Human tissue kallikrein 7, a novel biomarker for advanced ovarian carcinoma using a novel in situ quantitative method of protein expression. (2008) (31)
JQ1 inhibits tumour growth in combination with cisplatin and suppresses JAK/STAT signalling pathway in ovarian cancer. (2020) (31)
Pancreatic duct guidewire placement for biliary cannulation in a single-session therapeutic ERCP. (2011) (31)
Downregulation of the neonatal Fc receptor expression in non-small cell lung cancer tissue is associated with a poor prognosis (2016) (31)
Significance of Urokinase-Type Plasminogen Activator and Plasminogen Activator Inhibitor-1 (PAI-1) Expression in Human Colorectal Carcinomas (2002) (31)
Galectin-1 has potential prognostic significance and is implicated in clear cell renal cell carcinoma progression through the HIF/mTOR signaling axis (2017) (30)
TA Repeat Polymorphism of the 5α-Reductase Gene and Breast Cancer (2000) (30)
Prognostic and predictive biomarkers in prostate cancer (2015) (30)
Seroprevalence of Antibodies against SARS-CoV-2 among the Personnel and Students of the National and Kapodistrian University of Athens, Greece: A Preliminary Report (2020) (29)
Prognostic value of kallikrein‐related peptidase 6 protein expression levels in advanced ovarian cancer evaluated by automated quantitative analysis (AQUA) (2008) (29)
Polyvinylamine-streptavidin complexes labeled with a europium chelator: a universal detection reagent for solid-phase time resolved fluorometric applications. (2000) (29)
KLK11 mRNA expression predicts poor disease-free and overall survival in colorectal adenocarcinoma patients. (2014) (29)
Quantitative analysis of BCL2 mRNA expression in nasopharyngeal carcinoma: an unfavorable and independent prognostic factor (2010) (29)
High BAX/BCL2 mRNA ratio predicts favorable prognosis in laryngeal squamous cell carcinoma, particularly in patients with negative lymph nodes at the time of diagnosis. (2016) (29)
Long Noncoding RNAs in Digestive System Malignancies: A Novel Class of Cancer Biomarkers and Therapeutic Targets? (2015) (29)
Primary Tumor Levels of Human Tissue Kallikreins Affect Surgical Success and Survival in Ovarian Cancer Patients (2007) (28)
Molecular profile of breast versus ovarian cancer cells in response to treatment with the anticancer drugs cisplatin, carboplatin, doxorubicin, etoposide and taxol (2008) (28)
Expression analysis and study of KLK4 in benign and malignant breast tumours (2009) (28)
The role of circular RNAs in therapy resistance of patients with solid tumors. (2020) (28)
Elevated miR-20b-5p expression in peripheral blood mononuclear cells: A novel, independent molecular biomarker of favorable prognosis in chronic lymphocytic leukemia. (2018) (27)
Cathepsin B protein levels in endometrial cancer: Potential value as a tumour biomarker. (2009) (27)
Targeting kallikrein-related peptidases in prostate cancer (2014) (27)
Identification of novel alternative splice variants of the BCL2L12 gene in human cancer cells using next-generation sequencing methodology. (2016) (27)
Parallel overexpression and clinical significance of kallikrein-related peptidases 7 and 14 (KLK7 & KLK14) in colon cancer (2012) (27)
miR-125b predicts childhood acute lymphoblastic leukaemia poor response to BFM chemotherapy treatment (2017) (27)
Quantitative expression analysis and prognostic significance of the BCL2-associated X gene in nasopharyngeal carcinoma: a retrospective cohort study (2013) (27)
Cloning of a gene (SR-A1), encoding for a new member of the human Ser/Arg-rich family of pre-mRNA splicing factors: overexpression in aggressive ovarian cancer (2001) (27)
Kallikreins as Markers of Disseminated Tumour Cells in Ovarian Cancer – A Pilot Study (2006) (26)
Association between kallikrein-related peptidases (KLKs) and macroscopic indicators of semen analysis: their relation to sperm motility (2009) (26)
Human kallikrein-related peptidase 12 (KLK12) splice variants expression in breast cancer and their clinical impact (2012) (26)
Quantitative expression analysis of the apoptosis-related gene, BCL2L12, in head and neck squamous cell carcinoma. (2013) (26)
Cathepsin-D and c-erb-B 2 have an additive prognostic value for breast cancer patients. (1993) (25)
miR-10b is a prognostic marker in clear cell renal cell carcinoma (2017) (25)
High microRNA-28-5p expression in colorectal adenocarcinoma predicts short-term relapse of node-negative patients and poor overall survival of patients with non-metastatic disease (2018) (25)
Progression of mouse skin carcinogenesis is associated with the orchestrated deregulation of mir‐200 family members, mir‐205 and their common targets (2016) (25)
Copper(II) Inverse‐[9‐Metallacrown‐3] Compounds Accommodating Nitrato or Diclofenac Ligands: Structure, Magnetism, and Biological Activity (2016) (25)
Identification of a novel tRNA‐derived RNA fragment exhibiting high prognostic potential in chronic lymphocytic leukemia (2019) (25)
Topotecan and methotrexate alter expression of the apoptosis-related genes BCL2, FAS and BCL2L12 in leukemic HL-60 cells (2006) (25)
Enhanced antileukemic activity of the novel complex 2,5-dihydroxybenzoate molybdenum(VI) against 2,5-dihydroxybenzoate, polyoxometalate of Mo(VI), and tetraphenylphosphonium in the human HL-60 and K562 leukemic cell lines. (2007) (25)
Natural alkaloids intervening the insulin pathway: new hopes for anti-diabetic agents? (2019) (25)
KLKB1 mRNA overexpression: A novel molecular biomarker for the diagnosis of chronic lymphocytic leukemia. (2015) (25)
Kallikrein-related peptidase 13 (KLK13) gene expressional status contributes significantly in the prognosis of primary gastric carcinomas. (2010) (25)
Effect of doxorubicin, oxaliplatin, and methotrexate administration on the transcriptional activity of BCL-2 family gene members in stomach cancer cells (2013) (24)
Codon 89 polymorphism in the human 5 α -reductase gene in primary breast cancer (2001) (24)
Circulating exosomal miRNAs: clinical significance in human cancers (2019) (24)
mRNA overexpression of the hypoxia inducible factor 1 alpha subunit gene (HIF1A): An independent predictor of poor overall survival in chronic lymphocytic leukemia. (2017) (24)
Molecular characterization of a new gene, CEAL1, encoding for a carcinoembryonic antigen-like protein with a highly conserved domain of eukaryotic translation initiation factors. (2003) (23)
Down-regulation of kallikrein-related peptidase 5 (KLK5) expression in breast cancer patients: a biomarker for the differential diagnosis of breast lesions (2011) (23)
miR-34a overexpression predicts poor prognostic outcome in colorectal adenocarcinoma, independently of clinicopathological factors with established prognostic value. (2017) (23)
mRNA expression analysis of human kallikrein 11 (KLK11) may be useful in the discrimination of benign prostatic hyperplasia from prostate cancer after needle prostate biopsy (2006) (23)
MicroRNAs: Tiny Regulators of Gene Expression with Pivotal Roles in Normal B-Cell Development and B-Cell Chronic Lymphocytic Leukemia (2021) (23)
The single nucleotide polymorphism g.1548A >G (K469E) of the ICAM-1 gene is associated with worse prognosis in non-small cell lung cancer (2012) (23)
Quantified KLK15 Gene Expression Levels Discriminate Prostate Cancer From Benign Tumors and Constitute a Novel Independent Predictor of Disease Progression (2013) (22)
Expression and prognostic significance of kallikrein-related peptidase 8 protein levels in advanced ovarian cancer by using automated quantitative analysis (2009) (22)
Breast cancer prognostic significance of a single nucleotide polymorphism in the proximal androgen response element of the prostate specific antigen gene promoter (2000) (22)
Quantitative analysis of human kallikrein 5 (KLK5) expression in prostate needle biopsies: an independent cancer biomarker. (2009) (22)
c-erbB-2 overexpression may be used as an independent prognostic factor for breast cancer patients. (1995) (22)
Diagnostic and prognostic significance of human kallikrein 11 (KLK11) mRNA expression levels in patients with laryngeal cancer. (2012) (22)
High Clusterin (CLU) mRNA expression levels in tumors of colorectal cancer patients predict a poor prognostic outcome. (2019) (22)
The miR-200 family as prognostic markers in clear cell renal cell carcinoma. (2019) (22)
tRNA-Derived Fragments (tRFs) in Bladder Cancer: Increased 5′-tRF-LysCTT Results in Disease Early Progression and Patients’ Poor Treatment Outcome (2020) (22)
Next generation sequencing targeted gene panel in Greek MODY patients increases diagnostic accuracy (2020) (21)
L-DOPA decarboxylase mRNA expression is associated with tumor stage and size in head and neck squamous cell carcinoma: a retrospective cohort study (2012) (21)
miR‐221/222 cluster expression improves clinical stratification of non‐muscle invasive bladder cancer (TaT1) patients' risk for short‐term relapse and progression (2018) (21)
Kallikrein-related peptidase 6 (KLK6) expression in the progression of colon adenoma to carcinoma (2014) (21)
Expression analysis and study of the KLK15 mRNA splice variants in prostate cancer and benign prostatic hyperplasia (2010) (21)
BCL2L12: a promising molecular prognostic biomarker in breast cancer. (2014) (21)
A novel, mitochondrial, internal tRNA-derived RNA fragment possesses clinical utility as a molecular prognostic biomarker in chronic lymphocytic leukemia. (2020) (21)
Molecular Response of HL‐60 Cells to Mitotic Inhibitors Vincristine and Taxol Visualized with Apoptosis‐Related Gene Expressions, Including the New Member BCL2L12 (2009) (21)
Treatment of PC3 prostate cancer cells with mitoxantrone, etoposide, doxorubicin and carboplatin induces distinct alterations in the expression of kallikreins 5 and 11 (2009) (21)
L‐dopa decarboxylase (DDC) gene expression is related to outcome in patients with prostate cancer (2012) (20)
Identification of a novel, internal tRNA-derived RNA fragment as a new prognostic and screening biomarker in chronic lymphocytic leukemia, using an innovative quantitative real-time PCR assay. (2019) (20)
Profilin-1 expression is associated with high grade and stage and decreased disease-free survival in renal cell carcinoma. (2015) (20)
Expression of Bcl2L12 in chronic lymphocytic leukemia patients: association with clinical and molecular prognostic markers (2013) (20)
Alpha-enolase is a potential prognostic marker in clear cell renal cell carcinoma (2015) (20)
Predictions for the future of kallikrein-related peptidases in molecular diagnostics (2014) (19)
Free/Total PSA (F/T ratio) kinetics in patients with clinically localized prostate cancer undergoing radical prostatectomy. (2005) (19)
Novel splice variants of prostate-specific antigen and applications in diagnosis of prostate cancer. (2008) (19)
Clinical utility of microRNAs in renal cell carcinoma: current evidence and future perspectives (2018) (19)
Blood-based analysis of type-2 diabetes mellitus susceptibility genes identifies specific transcript variants with deregulated expression and association with disease risk (2019) (18)
Unravelling a p73-regulated network: The role of a novel p73-dependent target, MIR3158, in cancer cell migration and invasiveness. (2017) (18)
Comparative study of balloon and metal olive dilators for endoscopic management of benign anastomotic rectal strictures: clinical and cost-effectiveness outcomes (2011) (18)
MicroRNA-92a-3p overexpression in peripheral blood mononuclear cells is an independent predictor of prolonged overall survival of patients with chronic lymphocytic leukemia (2018) (18)
Cytotoxic activity of sunitinib and everolimus in Caki-1 renal cancer cells is accompanied by modulations in the expression of apoptosis-related microRNA clusters and BCL2 family genes. (2015) (18)
Treatment of Gastric Cancer Cells with 5-Fluorouracil/Leucovorin and Irinotecan Induces Distinct Alterations in the mRNA Expression of the Apoptosis-Related Genes, Including the Novel Gene BCL2L12 (2009) (18)
Relationships between cathepsin-D, pS2 protein and hormonal receptors in breast cancer cytosols: inconsistency with their established prognostic significance. (1997) (18)
Clinical utility of miR-143/miR-182 levels in prognosis and risk stratification specificity of BFM-treated childhood acute lymphoblastic leukemia (2018) (17)
The Multifaceted Role and Utility of MicroRNAs in Indolent B-Cell Non-Hodgkin Lymphomas (2021) (17)
KLK5 gene expression is severely upregulated in androgen-independent prostate cancer cells after treatment with the chemotherapeutic agents docetaxel and mitoxantrone (2010) (17)
Discovery of novel transcripts of the human tissue kallikrein (KLK1) and kallikrein-related peptidase 2 (KLK2) in human cancer cells, exploiting Next-Generation Sequencing technology. (2019) (17)
Evaluation of kallikrein-related peptidase 5 expression and its significance for breast cancer patients: association with kallikrein-related peptidase 7 expression. (2011) (17)
Dramatic suppression of plasma and urinary prostate specific antigen and human glandular kallikrein by antiandrogens in male-to-female transsexuals. (2000) (17)
Downregulated KLK13 expression in bladder cancer highlights tumor aggressiveness and unfavorable patients’ prognosis (2017) (16)
Low mRNA expression levels of kallikrein-related peptidase 4 (KLK4) predict short-term relapse in patients with laryngeal squamous cell carcinoma (2014) (16)
l-DOPA Decarboxylase (DDC) Expression Status as a Novel Molecular Tumor Marker for Diagnostic and Prognostic Purposes in Laryngeal Cancer. (2012) (16)
Evaluation and prognostic significance of human tissue kallikrein-related peptidase 10 (KLK10) in colorectal cancer (2012) (16)
The Stat3/5 Signaling Biosignature in Hematopoietic Stem/Progenitor Cells Predicts Response and Outcome in Myelodysplastic Syndrome Patients Treated with Azacitidine (2015) (16)
Clinical evaluation of microRNA-145 expression in renal cell carcinoma: a promising molecular marker for discriminating and staging the clear cell histological subtype (2016) (16)
Synthesis, spectroscopic study and anticancer activity of a water-soluble Nb(V) peroxo complex. (2011) (16)
Identification of Two Novel Circular RNAs Deriving from BCL2L12 and Investigation of Their Potential Value as a Molecular Signature in Colorectal Cancer (2020) (16)
Assessing the clinical value of microRNAs in formalin-fixed paraffin-embedded liposarcoma tissues: Overexpressed miR-155 is an indicator of poor prognosis (2016) (16)
Unraveling UCA1 lncRNA prognostic utility in urothelial bladder cancer. (2019) (15)
Multiple Myeloma Bone Disease: Implication of MicroRNAs in Its Molecular Background (2021) (15)
The transcriptome of a “sleeping” invader: de novo assembly and annotation of the transcriptome of aestivating Cornu aspersum (2017) (15)
Clinical relevance of the deregulated kallikrein-related peptidase 8 mRNA expression in breast cancer: a novel independent indicator of disease-free survival (2015) (15)
Identification of a STAT5 Target Gene, Dpf3, Provides Novel Insights in Chronic Lymphocytic Leukemia (2013) (15)
Multidisciplinary therapy of locally far-advanced or inflammatory breast cancer with fixed perioperative sequence of epirubicin, vinorelbine, and Fluorouracil chemotherapy, surgery, and radiotherapy: long-term results. (2006) (15)
Molecular cloning of novel transcripts of human kallikrein-related peptidases 5, 6, 7, 8 and 9 (KLK5 – KLK9), using Next-generation sequencing (2017) (15)
The role of transcription factors in laboratory medicine (2013) (15)
10-(2-Biotinyloxyethyl)-9-acridone: A novel fluorescent label for (strept)avidin–biotin based assays (2006) (14)
Quantitative expression analysis and study of the novel human kallikrein-related peptidase 14 gene (KLK14) in malignant and benign breast tissues (2010) (14)
Immunohistochemical localization and analysis of kallikrein-related peptidase 7 and 11 expression in paired cancer and benign foci in prostate cancer patients. (2011) (14)
Enhanced concentration-dependent cytotoxic effect of the dinuclear copper(II) complex of L-carnitine [Cu2(L-carnitine)2Cl2(H2O)2]Cl2, compared to L-carnitine or copper chloride dihydrate, in human leukemic cell lines. (2008) (14)
Blood-based analysis of 84 microRNAs identifies molecules deregulated in individuals with type-2 diabetes, risk factors for the disease or metabolic syndrome. (2020) (14)
Kallikrein-related peptidase 6 (KLK6)gene expression in intracranial tumors (2012) (14)
Increased BCL2L12 expression predicts the short-term relapse of patients with TaT1 bladder cancer following transurethral resection of bladder tumors. (2014) (14)
S100A11 is a potential prognostic marker for clear cell renal cell carcinoma (2015) (14)
Expression analysis and prognostic significance of the SRA1 gene, in ovarian cancer. (2006) (14)
Identification and molecular cloning of novel transcripts of the human kallikrein-related peptidase 10 (KLK10) gene using next-generation sequencing. (2017) (14)
Comparison of the percent free prostate-specific antigen levels in the serum of healthy men and in men with recurrent prostate cancer after radical prostatectomy. (2000) (14)
Effect of testosterone administration on serum and urine kallikrein concentrations in female-to-male transsexuals. (2006) (14)
HPV16 E6/E7 expression in circulating tumor cells in oropharyngeal squamous cell cancers: A pilot study (2019) (14)
Kallikrein-related peptidase 13: an independent indicator of favorable prognosis for patients with nonsmall cell lung cancer (2015) (14)
Heat shock protein beta 3 (HSPB3) is an unfavorable molecular biomarker in colorectal adenocarcinoma (2019) (13)
Overexpression of the novel member of the BCL2 gene family, BCL2L12, is associated with the disease outcome in patients with acute myeloid leukemia. (2012) (13)
Alternative Splicing Detection Tool-a novel PERL algorithm for sensitive detection of splicing events, based on next-generation sequencing data analysis. (2018) (13)
mRNA overexpression of kallikrein-related peptidase 14 (KLK14) is an independent predictor of poor overall survival in chronic lymphocytic leukemia patients (2016) (13)
Cisplatin and Paclitaxel Alter the Expression Pattern of miR‐143/145 and miR‐183/96/182 Clusters in T24 Bladder Cancer Cells (2015) (13)
SR-A1, a member of the human pre-mRNA splicing factor family, and its expression in colon cancer progression (2004) (12)
B 7-H 4 is over-expressed in early-stage ovarian cancer and is independent of CA 125 expression (2007) (12)
Extracellular domain of HER2: a useful marker for the initial workup and follow-up of HER2-positive breast cancer. (2008) (12)
Quantitative analysis and study of the mRNA expression levels of apoptotic genes BCL2, BAX and BCL2L12 in the articular cartilage of an animal model of osteoarthritis. (2018) (12)
Novel alternative splice variants of the human protein arginine methyltransferase 1 (PRMT1) gene, discovered using next-generation sequencing. (2019) (12)
Cathepsin D may help in discriminating node-negative breast cancer patients at risk for local-regional recurrence. (1998) (12)
tRNAGlyGCC-Derived Internal Fragment (i-tRF-GlyGCC) in Ovarian Cancer Treatment Outcome and Progression (2021) (12)
Identification and characterization of a novel human testis-specific kinase substrate gene which is downregulated in testicular tumors. (2001) (11)
Novel splice variants of the human kallikrein-related peptidases 11 (KLK11) and 12 (KLK12), unraveled by next-generation sequencing technology (2018) (11)
Gemcitabine impacts differentially on bladder and kidney cancer cells: distinct modulations in the expression patterns of apoptosis-related microRNAs and BCL2 family genes (2015) (11)
Significant alterations in the expression pattern of kallikrein-related peptidase genes KLK4, KLK5 and KLK14 after treatment of breast cancer cells with the chemotherapeutic agents epirubicin, docetaxel and methotrexate (2013) (11)
Poly(A)polymerase activity levels in breast tumour cytosols. (1998) (11)
Genomic Organization of the Human Kallikrein Gene (2000) (11)
The kallikrein-related peptidase 13 (KLK13) gene is substantially up-regulated after exposure of gastric cancer cells to antineoplastic agents (2012) (10)
Pediatric Ependymoma: A Proteomics Perspective. (2017) (10)
Human kallikrein-related peptidase 12 (KLK12) splice variants discriminate benign from cancerous breast tumors. (2018) (10)
SARS-CoV-2 Infection Is Asymptomatic in Nearly Half of Adults with Robust Anti-Spike Protein Receptor-Binding Domain Antibody Response (2021) (10)
miR-203 is an independent molecular predictor of prognosis and treatment outcome in ovarian cancer: a multi-institutional study. (2020) (10)
l-Dopa decarboxylase (DDC) constitutes an emerging biomarker in predicting patients’ survival with stomach adenocarcinomas (2013) (10)
Prognostic significance of the expression of SR-A1, encoding a novel SR-related CTD-associated factor, in breast cancer (2006) (10)
Overexpression of BCL2 and BAX following BFM induction therapy predicts ch-ALL patients’ poor response to treatment and short-term relapse (2015) (10)
Comparative HPLC-DAD and UHPLC-ESI(-)-HRMS & MS/MS profiling of Hypericum species and correlation with necrotic cell-death activity in human leukemic cells (2017) (10)
TA repeat polymorphism of the 5alpha-reductase gene and breast cancer. (2000) (10)
Expression of the C-terminal domain of novel human SR-A1 protein: interaction with the CTD domain of RNA polymerase II. (2005) (9)
Expression Analysis of miR‐29b in Malignant and Benign Breast Tumors: A Promising Prognostic Biomarker for Invasive Ductal Carcinoma With a Possible Histotype‐Related Expression Status (2017) (9)
Cathepsin D concentration in tumor cytosols improves the accuracy of prognostic evaluation of primary breast cancer. (1997) (9)
p 27 kip 1 and Ki-67 ( MIB 1 ) Immunohistochemical Expression in Radical Prostatectomy Specimens of Patients with Clinically Localized Prostate Cancer (2009) (9)
BCL2L12 protein overexpression is associated with favorable outcome in diffuse large B-cell lymphoma patients in the rituximab era (2016) (9)
The Immunohistochemical Expression of Growth Hormone-Releasing Hormone Receptor Splice Variant 1 Is a Favorable Prognostic Marker in Colorectal Cancer (2009) (9)
Kallikrein-related peptidases and associated microRNAs as promising prognostic biomarkers in gastrointestinal malignancies (2018) (9)
DDC (dopa decarboxylase (aromatic L-amino acid decarboxylase)) (2012) (9)
A Molecular Signature of Circulating MicroRNA Can Predict Osteolytic Bone Disease in Multiple Myeloma (2021) (9)
Safety and Efficacy of Trastuzumab Every 3 Weeks Combined with Cytotoxic Chemotherapy in Patients with HER2-Positive Recurrent Breast Cancer: Findings from a Case Series (2005) (9)
Discovery and expression analysis of novel transcripts of the human SR-related CTD-associated factor 1 (SCAF1) gene in human cancer cells using Next-Generation Sequencing. (2018) (9)
Unraveling novel survivin mRNA transcripts in cancer cells using an in-house developed targeted high-throughput sequencing approach. (2020) (9)
Novel biotinylated acridinium derivatives: new reagents for fluorescence immunoassays and proteomics. (2005) (9)
Kallikrein-related peptidase 6 (KLK6) expression differentiates tumor subtypes and predicts clinical outcome in breast cancer patients (2018) (9)
Metformin and Anti-Cancer Therapeutics: Hopes for a More Enhanced Armamentarium Against Human Neoplasias? (2017) (9)
Erlotinib monotherapy in patients with advanced non-small cell lung cancer: an effective approach with low toxicity. (2008) (8)
Next-generation sequencing reveals alternative L-DOPA decarboxylase (DDC) splice variants bearing novel exons, in human hepatocellular and lung cancer cells. (2020) (8)
Cloning, physical mapping and structural characterization of the human alpha(A)-adaptin gene. (2002) (8)
L-DOPA decarboxylase mRNA levels provide high diagnostic accuracy and discrimination between clear cell and non-clear cell subtypes in renal cell carcinoma. (2015) (8)
The expression of the CEACAM 19 gene , a novel member of the CEA family , is associated with breast cancer progression (8)
Evidence for L-Dopa Decarboxylase Involvement in Cancer Cell Cytotoxicity Induced by Docetaxel and Mitoxantrone. (2019) (8)
miRNA-seq and clinical evaluation in multiple myeloma: miR-181a overexpression predicts short-term disease progression and poor post-treatment outcome (2021) (8)
miR‐181a overexpression predicts the poor treatment response and early‐progression of serous ovarian cancer patients (2020) (8)
Molecular Effects of Treatment of Human Colorectal Cancer Cells with Natural and Classical Chemotherapeutic Drugs: Alterations in the Expression of Apoptosis-related BCL2 Family Members, Including BCL2L12. (2019) (8)
Immunohistochemical expression of somatostatin receptor subtypes 2 and 5 in colorectal cancer (2012) (8)
A 3′ tRNA‐derived fragment produced by tRNALeuAAG and tRNALeuTAG is associated with poor prognosis in B‐cell chronic lymphocytic leukemia, independently of classical prognostic factors (2021) (8)
BCL2L12 improves risk stratification and prediction of BFM-chemotherapy response in childhood acute lymphoblastic leukemia (2018) (7)
Uncovering the clinical impact of kallikrein-related peptidase 5 (KLK5) mRNA expression in the colorectal adenoma-carcinoma sequence (2019) (7)
Identification of novel alternative splice variants of the human L-DOPA decarboxylase (DDC) gene in human cancer cells, using high-throughput sequencing approaches. (2019) (7)
Total and free PSA kinetics in patients without prostate cancer undergoing radical cystoprostatectomy (2008) (7)
Novel Nested-Seq Approach for SARS-CoV-2 Real-Time Epidemiology and In-Depth Mutational Profiling in Wastewater (2021) (7)
Kallikrein‐related peptidases (KLKs) as novel potential biomarkers in gastric cancer: An open yet challenging road lies ahead (2012) (7)
The kallikreins: old proteases with new clinical potentials (2013) (6)
Molecular cloning of novel transcripts of the adaptor-related protein complex 2 alpha 1 subunit (AP2A1) gene, using Next-Generation Sequencing. (2018) (6)
Serum and urine tissue kallikrein concentrations in male-to-female transsexuals treated with antiandrogens and estrogens. (2006) (6)
A comprehensive clinicopathological evaluation of the differential expression of microRNA-331 in breast tumors and its diagnostic significance. (2018) (6)
Human L-DOPA decarboxylase mRNA is a target of miR-145: A prediction to validation workflow. (2015) (6)
Nanopore Sequencing Unveils Diverse Transcript Variants of the Epithelial Cell-Specific Transcription Factor Elf-3 in Human Malignancies (2021) (6)
Gene-Specific Intron Retention Serves as Molecular Signature that Distinguishes Melanoma from Non-Melanoma Cancer Cells in Greek Patients (2019) (6)
High Expression of a tRNAPro Derivative Associates with Poor Survival and Independently Predicts Colorectal Cancer Recurrence (2022) (5)
Immunohistochemical Expression of Bcl 2 is an Independent Predictor of Time-to-biochemical Failure in Patients with Clinically Localized Prostate Cancer Following Radical Prostatectomy (2009) (5)
Revised Exon Structure of l-DOPA Decarboxylase (DDC) Reveals Novel Splice Variants Associated with Colorectal Cancer Progression (2020) (4)
Molecular Biomarkers of Laryngeal Cancer Laryngeal squamous cell carcinoma (LSCC) Tumor markers (2015) (4)
Contribution of miRNAs, tRNAs and tRFs to Aberrant Signaling and Translation Deregulation in Lung Cancer (2020) (4)
A versatile 5′ RACE-Seq methodology for the accurate identification of the 5′ termini of mRNAs (2022) (4)
Effect of bleomycin and cisplatin on the expression profile of SRA1, a novel member of pre-mRNA splicing factors, in HL-60 human promyelocytic leukemia cells (2007) (4)
Complex transcriptional regulation of the BCL2L12 gene: novel, active promoter in K562 cells. (2020) (4)
Highly Sensitive Array Analysis Using Time Resolved Fluorescence and a Novel Streptavidin-Based Reagent (2002) (3)
Genetic alterations in HRAS gene in relation to outcome and response to cetuximab in head and neck squamous cell carcinoma. (2012) (3)
Identification and expression analysis of novel splice variants of the human carcinoembryonic antigen-related cell adhesion molecule 19 (CEACAM19) gene using a high-throughput sequencing approach. (2020) (3)
Overexpression of the GR Riborepressor LncRNA GAS5 Results in Poor Treatment Response and Early Relapse in Childhood B-ALL (2021) (3)
Quantification and study of the L-DOPA decarboxylase expression in gastric adenocarcinoma cells treated with chemotherapeutic substances (2013) (3)
tRNA Derivatives in Multiple Myeloma: Investigation of the Potential Value of a tRNA-Derived Molecular Signature (2021) (3)
Human kallikrein 5 (hK5): A hovel serum biomarker for ovarian and breast cancer. (2003) (3)
Translation Regulation by microRNAs in Acute Leukemia (2014) (3)
BCL2L12: a multiply spliced gene with independent prognostic significance in breast cancer (2018) (3)
mRNA quantification and clinical evaluation of telomerase reverse transcriptase subunit (hTERT) in intracranial tumours of patients in the island of Crete (2005) (3)
ΔNp63 transcript loss in bladder cancer constitutes an independent molecular predictor of TaT1 patients post-treatment relapse and progression (2019) (3)
Elevated levels of both microRNA 378 (miR-378) and kallikrein-related peptidase 4 (KLK4) mRNA are associated with an unfavorable prognosis in triple-negative breast cancer. (2021) (3)
Multianalyte quantitative competitive PCR on optically encoded microspheres for an eight-gene panel related to prostate cancer (2017) (3)
Identification and expression analysis of ten novel small non-coding RNAs (sncRNAs) in cancer cells using a high-throughput sequencing approach. (2021) (3)
A Cancer-Related microRNA Signature Shows Biomarker Utility in Multiple Myeloma (2021) (3)
Epi‐miRNAs: Modern mediators of methylation status in human cancers (2022) (3)
Editorial (Thematic Issue: The Effects of Anticancer Agents on Cell Apoptosis and on the Expression of Cancer - Related Genes) (2014) (3)
Kallikreins as Biomarkers in Human Malignancies (2014) (3)
PDL1-expressing circulating tumor cells (CTCs) in head and neck squamous cell carcinoma (HNSCC). (2015) (3)
Expressional profiling and clinical relevance of RNase κ in prostate cancer: a novel indicator of favorable progression-free survival (2018) (3)
Identification of Novel Circular RNAs of the Human Protein Arginine Methyltransferase 1 (PRMT1) Gene, Expressed in Breast Cancer Cells (2022) (3)
Jagged Ends of Cell-Free DNA: Rebranding Fragmentomics in Modern Liquid Biopsy Diagnostics. (2021) (2)
Identification of novel alternative transcripts of the human Ribonuclease κ (RNASEK) gene using 3' RACE and high-throughput sequencing approaches. (2019) (2)
Delta SARS-CoV-2 variant is entirely substituted by the omicron variant during the fifth COVID-19 wave in Attica region (2022) (2)
Highlight: the 4th International Symposium on Kallikreins and Kallikrein-related peptidases. (2012) (2)
Expression analysis of miR-29 b in malignant and benign breast tumors : a promising biomarker for the differential diagnosis and prognosis of lobular and ductal adenocarcinomas (2017) (2)
Pharmacoepigenomics circuits induced by a novel retinoid-polyamine conjugate in human immortalized keratinocytes (2021) (2)
A Molecular Signature of Three tRNA-Derived RNA Fragments May Discriminate Smoldering from Symptomatic Multiple Myeloma Patients (2019) (2)
BCL2L12 (BCL2-like 12 (proline-rich)) (2011) (2)
BOK (BCL2 family apoptosis regulator BOK) (2019) (2)
Epigenetic regulation of MIR145 core promoter controls miR-143/145 cluster in bladder cancer progression and treatment outcome (2022) (2)
Human Kal l ikre in 6 ( hK 6 ) : A New Potent ia l Serum Biomarker for Diagnosis and Prognosis of Ovar ian Carc inoma (2003) (2)
Targeted Long-Read Sequencing Decodes the Transcriptional Atlas of the Founding RAS Gene Family Members. (2021) (1)
Molecular characterization, genomic structure and expression analysis of a gene (CATL1/CPT1C) encoding a third member of the human carnitine acyltransferase family. (2019) (1)
BAX (BCL2-associated X protein) (2011) (1)
Structural characterization and expression analysis of novel MAPK1 transcript variants with the development of a multiplexed targeted nanopore sequencing approach. (2022) (1)
Loss of GAS5 tumour suppressor lncRNA: an independent molecular cancer biomarker for short-term relapse and progression in bladder cancer patients (2018) (1)
Evaluation of the clinical utility of kallikrein-related peptidase 6 gene (KLK6) downregulation in breast cancer. (2012) (1)
Prostase/KLK-L1 is differentially expressed in normal/benign versus malignant ovarian tissues (2000) (1)
Interplay between Sulfur Assimilation and Biodesulfurization Activity in Rhodococcus qingshengii IGTS8: Insights into a Regulatory Role of the Reverse Transsulfuration Pathway (2022) (1)
THE tRNA‐DERIVED RNA FRAGMENTS (tRFs) BEARING THE GLYCINE ANTICODONS GCC AND CCC AS EMERGING MOLECULAR BIOMARKERS OF UNFAVORABLE PROGNOSIS IN CHRONIC LYMPHOCYTIC LEUKEMIA (2019) (1)
The Clinical Significance of a Novel microRNA Signature in Multiple Myeloma (2019) (1)
Lactate Dehydrogenase A is a potential prognostic marker in clear cell renal cell carcinoma (2014) (1)
Artificial Intelligence: The Milestone in Modern Biomedical Research (2022) (1)
MicroRNA 224: a KLK-targeting miRNA with dregulated expression and promising prognostic value in prostate cancer (2013) (1)
1 Genomic Structure of the KLK Locus (2012) (1)
Recent Advances in Genome-Engineering Strategies (2023) (1)
KLK12 (kallikrein-related peptidase 12) (2018) (1)
Sensitizing HRAS overexpressing head and neck squamous cell carcinoma (HNSCC) to chemotherapy (2019) (1)
High mRNA Expression Levels of Heat Shock Protein Family B Member 2 (HSPB2) Are Associated with Breast Cancer Patients’ Relapse and Poor Survival (2022) (1)
A comprehensive nanopore sequencing methodology deciphers the complete transcriptional landscape of cyclin‐dependent kinase 4 (CDK4) in human malignancies (2021) (1)
SCAF1 (SR-related CTD-associated factor 1) (2011) (1)
Blood-based analysis of type-2 diabetes mellitus susceptibility genes identifies specific transcript variants with deregulated expression and association with disease risk (2019) (0)
The interplay between sulfur metabolism and desulfurization profile in Rhodococcus: Unraveling the role of the transsulfuration pathway (2022) (0)
The transcriptome of a “sleeping” invader: de novo assembly and annotation of the transcriptome of aestivating Cornu aspersum (2017) (0)
Expression and Clinical Evaluation of Klk10 Gene in Colon Cancer (2011) (0)
ID: 312 Distinct alterations in the expression levels of SRA1 gene, in the breast cancer cell line MCF7, as a response to treatment with anticancer drugs. (2006) (0)
Cytotoxic and pro-apoptotic effects of Hypericum species. Metabolites profiling and dereplication procedures for the identification of bioactive ingredients (2014) (0)
Human kallikrin 6 (hK6) and 10 (hK10): new potential serum biomarkers for diagnosis and prognosis of epithelial ovarian cancer (2002) (0)
LowExpressionofmiR-126IsaPrognosticMarker for Metastatic Clear Cell Renal Cell Carcinoma (2015) (0)
Dinucleotide repeat length polymorphism on the 3 untranslated region of the SRD5A2 gene in breast cancer (2001) (0)
Abstract LB-72: Expression of theBCL2-like 12(BCL2L12) gene is associated with prolonged survival of breast adenocarcinoma patients. (2013) (0)
Multianalyte assay for prostate cancer-related gene quantification by hybridization on fluorescent microspheres (2015) (0)
Evaluation of the prognostic significance of human kallikrein 8 protein expression levels in advanced ovarian cancer by using automated quantitative protein analysis (2007) (0)
Advancing Desulfurization in the Model Biocatalyst Rhodococcus qingshengii IGTS8 via an In Locus Combinatorial Approach (2023) (0)
Prognost ic Value of the Human Kal l ikre in Gene 15 Express ion in Ovar ian Cancer (2003) (0)
Quantitative expression analysis and prognostic significance of the BCL2-associated Xgene in nasopharyngeal carcinoma: a retrospective cohort study (2013) (0)
Home Genes Leukemias Tumors Cancer prone Deep Insight Case Reports Portal Journals Teaching X Y 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 NA (2009) (0)
Manfred Schmitt (1947–2018) (2018) (0)
Cloning of a human gene, encoding a member of the Ser/Arg-rich family of proteins that interact with RNA Pol-II (2000) (0)
A versatile 5′ RACE-Seq methodology for the accurate identification of the 5′ termini of mRNAs (2022) (0)
Subject Index Vol. 22, 2001 (2001) (0)
Editorial: The effects of anticancer agents on cell apoptosis and on the expression of cancer-related genes. (2014) (0)
KLK9 (kallikrein-related peptidase 9) (2018) (0)
Corrigendum to “Delta SARS-CoV-2 variant is entirely substituted by the omicron variant during the fifth COVID-19 wave in Attica region” [Sci. Total Environ., 856(Pt 1) (2023)/159062] (2022) (0)
Down-Regulationof theHumanKallikreinGene 5 ( KLK 5 ) in ProstateCancerTissues (2002) (0)
Human kallikrein 6 (kH6): A potential serum tumor marker for diagnosis and prognosis of ovarian cancer (2002) (0)
Serum H uman G landular K allikrein-2 P rotease L evels Predict t he P resence o f P rostate C ancer A mong M en W ith Elevated P rostate-Specifi c A ntigen (2000) (0)
The Prostate 54 : 220 ^ 229 ( 2003 ) SerumHumanGlandularKallikrein ( hK 2 ) and Insulin-LikeGrowth Factor 1 ( IGF-1 ) Improve theDiscriminationBetweenProstateCancer andBenign ProstaticHyperplasia in CombinationWithTotaland % Free PSA (2002) (0)
BCL2L12: A highly complex gene locus with possible clinical utility in breast cancer (2015) (0)
Prognostic V alue o f t he H uman K allikrein G ene 1 5 E xpression in O varian C ancer (2003) (0)
Evaluation of the Small Heat Shock Protein Family Members HSPB2 and HSPB3 in Bladder Cancer Prognosis and Progression (2023) (0)
The Transition from Cancer “omics” to “epi-omics” through Next- and Third-Generation Sequencing (2022) (0)
tRNA-derived small RNA 3'U-tRFValCAC promotes tumour migration and early progression in ovarian cancer. (2022) (0)
The International Society for Enzymology: a glorious history, a golden legacy (2018) (0)
EP1277 Clinical evaluation of miR-34a in ovarian carcinoma (2019) (0)
miRNA-seq identification and clinical validation of CD138+ and circulating miR-25 in treatment response of multiple myeloma (2023) (0)
Preoperative Cell-Free DNA (cfDNA) in Muscle-Invasive Bladder Cancer Treatment Outcome. (2023) (0)
KLK14 (kallikrein-related peptidase 14) (2018) (0)
PIK3CA as a molecular target in mantle cell lymphoma (2008) (0)
1413 POSTER Expression Analysis and Study of BCL2 and the Novel Member of the Apoptotic Genes BCL2L12, as Promising Biomarkers for Monitoring of Prostate Cancer Cells' Response to Chemotherapy (2011) (0)
Atlas of Genetics and Cytogenetics in Oncology and Haematology (2009) (0)
ID: 316 Real-time PCR analysis of BCL2L12, a novel member of BCL2 family of the apoptosis-related genes, in human leukemia. (2006) (0)
Journal Pre-proof Epigenetic regulation of MIR145 core promoter controls miR-143/145 cluster in bladder cancer progression and treatment outcome (2022) (0)
Association of BCL2L12 overexpression with prolonged disease-free survival in breast cancer. (2014) (0)
1- Downregulation of the KLK2 - & KLK4 - targeting miR-378a predicts the short-term relapse of prostate cancer patients (2013) (0)
PP11 Expression differences of proteolytic factors uPA, PAI-1, and seven kallikrein-related peptidases (KLK5, 6, 7, 8, 10, 11, 13) between primary tumor and omentum metastasis impact outcome in advanced ovarian cancer (2009) (0)
KLK6 (kallikrein-related peptidase 6) (2020) (0)
miR-15a-5p, A Novel Prognostic Biomarker, Predicting Recurrent Colorectal Adenocarcinoma (2017) (0)
P595: DISCOVERY OF NOVEL CIRCULAR RNAS (CIRCRNAS) OF THE APOPTOSIS-RELATED BAX AND BCL2L12 GENES WITH A MULTIFACETED ROLE IN CHRONIC LYMPHOCYTIC LEUKEMIA, USING CUTTING-EDGE NANOPORE SEQUENCING TECHNOLOGY (2022) (0)
S100A11 is a potential prognostic marker for clear cell renal cell carcinoma (2015) (0)
Human K allikrein 6 ( hK6): A N ew P otential S erum B iomarker for D iagnosis a nd P rognosis o f O varian C arcinoma (2003) (0)
Can BCL2L12 be a promising favorable prognostic biomarker in breast cancer (2013) (0)
Evidence for the implication of human DDC and carbidopa in human cancer cell viability (2014) (0)
Quantitative expression analysis of the apoptotic gene BCL2L12 in breast cancer: association with clinical and molecular prognostic parameters (2014) (0)
A novel microrna signature with clinical significance in multiple myeloma (2020) (0)
Differential Expressionof theHumanKallikreinGene 14 ( KLK 14 ) inNormalandCancerous ProstaticTissues (2003) (0)
Repression of miR-146a in predicting poor treatment outcome in triple-negative breast cancer. (2022) (0)
326 POSTER Prognostic significance of human kallikrein 7 protein expression levels in ovarian cancer by using automated quantitative analysis (2006) (0)
The Cancer-Related Circrna Cirs-7 (CDR1-AS) Is Differentially Expressed in CD138+ Cells of Patients with Plasma Cell Disorders and Predicts Unfavorable Overall Survival in Multiple Myeloma (2022) (0)
Unveiling the Human Gastrointestinal Tract Microbiome: The Past, Present, and Future of Metagenomics (2023) (0)
Contents Vol. 22, 2001 (2001) (0)
Subject Index Vol. 24, 2003 (2004) (0)
Biomarkers with Prognostic Potential in Prostate Cancer (2018) (0)
Abstract A183: Identification of an exon 31-deletion variant of Notch1 receptor with frequent expression in head and neck cancer. (2013) (0)
10 Kallikrein-related Peptidases as Biomarkers in Personalized Cancer Medicine (2012) (0)
KLK13 (kallikrein-related peptidase 13) (2018) (0)
Translating transcriptome to immunophenotype in head and neck squamous cell carcinoma (HNSCC) to identify pathways promoting T-cell infiltration. (2019) (0)
Molecular cloning of novel transcripts of human kallikrein-related peptidases 5, 6, 7, 8 and 9 (KLK5 – KLK9), using Next-generation sequencing (2017) (0)
miRNA-seq and clinical evaluation in multiple myeloma: miR-181a overexpression predicts short-term disease progression and poor post-treatment outcome (2021) (0)
Abstract 2006: Identification and molecular cloning of novel splicing variants ofBCL2L12, a new member of theBCL2family, and their expression analysis in breast, prostate, and colon cancer cells (2012) (0)
COVID-19 mRNA vaccine-induced adverse effects: unwinding the unknowns (2022) (0)
Identification of six novel alternative transcripts of the human kallikrein-related peptidase 15 (KLK15), using 3'RACE and high-throughput sequencing. (2020) (0)
Alpha-enolase is a potential prognostic marker in clear cell renal cell carcinoma (2015) (0)
P-059: miRNA profiling of CD138+ plasma cells identifies miR-181a-5p overexpression as independent predictor of short-term progression and poor treatment outcome in multiple myeloma (2021) (0)
Decoding the concealed transcriptional signature of the apoptosis-related BCL2 antagonist/killer 1 (BAK1) gene in human malignancies (2022) (0)
The interplay between sulfur assimilation and biodesulfurization phenotype in Rhodococcus qingshengii IGTS8: Insights into a regulatory role of the reverse transsulfuration pathway (2022) (0)
962P Immunotherapeutic implications of mucin 1/16 expression in head and neck squamous cell carcinoma (HNSCC) (2020) (0)
The Repertoire of RNA Modifications Orchestrates a Plethora of Cellular Responses (2023) (0)
ID: 220 CLINICAL SIGNIFICANCE AND CO-EXPRESSION OF KLK5 AND KLK7 IN BREAST CANCER (2006) (0)
S115 KALLIKREIN-RELATED PEPRIDASE 13 (KLK 13) GENE EXPRESSION IN URINARY BLADDER CANCER: CLINICAL EVALUATION AND PRELIMINARY RESULTS (2012) (0)
142 POSTER The role of the novel apoptosis related gene BCL2L12 in prognosis and individualized treatment of breast cancer: a molecular and clinical approach (2006) (0)
Investigation of the effect of chemotherapeutic drugs on the multiple expression levels of the KLKs, DDC, RNASEK and BCL2L12 genes in human breast and prostate cancer cells. New promising indicators for predicting chemotherapy response (2016) (0)
L-DOPA decarboxylase mRNA expression is associated with tumor stage and size in head and neck squamous cell carcinoma: a retrospective cohort study (2012) (0)
Level differentials of proteolytic factors uPA, PAI-1 and human kallikreins (hK) 5,6,7,8,10,11,13 in primary ovarian carcinoma tissues and corresponding omentum metastases impact on disease outcome (2005) (0)
Contents Vol. 24, 2003 (2004) (0)
P415: TARGETED 3RD-GENERATION (NANOPORE) SEQUENCING REVEALS MANY NOVEL CIRCULAR RNAS OF THE APOPTOSIS-RELATED BCL2L12 GENE, EXPRESSED IN HUMAN CELLS FROM ACUTE MYELOID LEUKEMIA AND MYELODYSPLASTIC SYNDROMES (2022) (0)
Impact of proteolytic factors on surgical success and survival in ovarian cancer (2005) (0)
Impact of proteolytic factors (uPA, PAI-I, tissue kallikreins) on surgical success and survival in ovarian cancer (2005) (0)
The interplay between miR-1245a and BRCA2 in colorectal cancer (2020) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Andreas Scorilas?

Andreas Scorilas is affiliated with the following schools:

University of Toronto
National and Kapodistrian University of Athens

Andreas Scorilas's Academic­Influence.com Rankings

Why Is Andreas Scorilas Influential?

Andreas Scorilas's Published Works

Published Works

What Schools Are Affiliated With Andreas Scorilas?

Andreas Scorilas's AcademicInfluence.com Rankings